News Roundup: ACIP Recommends Pfizer Vaccine, FDA Delays Moderna EUA for Teens


Here’s a roundup of the latest news from Drug Topics®.

news roundup

Expert Interview: NACDS CEO Steven Anderson on the Power of Association

Steven Anderson, CEO, NACDS, joined Drug Topics® for a forward look at how associations—like the National Association of Chain Drug Stores—can empower pharmacies through collaboration in 2022.

Watch the interview

Drug Topics Salary Survey 2021

We need your opinions for the Drug Topics® 2021 Salary Survey.

Tell us about your workplace experience this year: from stress to compensation and everything in between, Finish the survey, and we’ll enter you into a drawing for 1 of 4 $100 Visa gift cards.* Take the survey now (*see survey rules for details.)

Take the survey

Prioritizing the Mental Health of Providers Across the Country

Susan Lorenz-Fisher, vice president of corporate responsibility & sustainability, AmerisourceBergen, and Erin Briggs, senior pharmacy advisor, Americares, discuss mental health awareness and resources for pharmacists to support their mental health.

Listen to the podcast

In Unanimous Vote, ACIP Recommends Pfizer-BioNTech COVID-19 Vaccine for Children Ages 5 to 11

The next step in the approval process is the formal acceptance of the recommendation by CDC Director Rochelle P. Walensky, MD, MPH.

Read more

First Participant Enrolled in Trial for Vaccine to Treat Opioid Disorders

A vaccine that prevents oxycodone from entering the brain? This might be the safe, long-lasting, cost-effective solution for opioid use disorders.

Read more

FDA Delays Adolescent COVID-19 Vaccine EUA Announcement for Moderna Vaccine

The FDA has notified Moderna that it will need additional time to complete its evaluation of the company’s EUA request for the use of its COVID-19 vaccine at the 100 µg dose level in adolescents between 12 and 17 years.

Read more

Related Videos
© 2024 MJH Life Sciences

All rights reserved.